Clinical trial
Evaluation of the Long-term Efficacy of the Injection of Botulinum Toxin A Into the Salivary Glands Versus Scopolamine Patches in the Treatment of Drooling in Children Over 4 Years Old With Cerebral Palsy.
NCT03616067 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Long-term Efficacy of the Injection of Botulinum Toxin A Into the Salivary Glands Versus Scopolamine Patches in the Treatment of Drooling in Children Over 4 Years Old With Cerebral Palsy.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- April 27, 2022
- Completion date
- September 22, 2025
- Enrollment
- 23 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.